Meeting Thu, 03/17/2022 - 12:00 Drug Prior Authorization Committee Meeting Information

Date
Media
Edit Implementation Schedule March 2022
PDL Announcements March 2022
PDL Recommendations March 2022
New Drugs Edits March 2022
Conduent Reports March 2022
Asthma Policy Update March 2022
Agenda
Agenda March 2022
Minutes
Minutes March 2022
Criteria
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
Imcivree March 2022
Megestrol Acetate March 2022
Nulibry March 2022
Oxervate March 2022
Oxlumo March 2022
Spravato March 2022
Zokinvy March 2022
Zulresso March 2022
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
Acne or Rosacea Select Topical Agents March 2022
C5 Complement Inhibitors March 2022
CFTR Modulators March 2022
Fabry Disease March 2022
Givlaari March 2022
Isturisa March 2022
Scenesse March 2022
Sickle Cell Disease March 2022
Systemic Antifungals March 2022
Tavneos March 2022
Voxzogo March 2022
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
Actinic Keratosis Agents Topical March 2022
Androgenic Agents March 2022
Antibiotics Inhaled March 2022
Antifungals Oral March 2022
Antifungals Topical March 2022
Antihistamines and Antihistamine-Decongestant Combos 2nd Gen March 2022
Antihistamines Intranasal March 2022
Antivirals Herpes Oral March 2022
Antivirals Topical March 2022
Benzoyl Peroxide Antibiotic Combos March 2022
Corticosteriods Oral Inhaled March 2022
Corticosteroids and Rhinitis Agents Intranasal March 2022
Corticosteroids Topical March 2022
Cough Cold Preparation March 2022
Epinephrine Agents Self Injectable March 2022
Fluoroquinolones Ophthalmic March 2022
Fluoroquinolones Otic March 2022
Glaucoma Agents March 2022
Mast Cell Stabilizers Ophthalmic March 2022
NSAIDS Ophthalmic March 2022
Psoriasis Agents Oral March 2022
Psoriasis Agents Topical March 2022
Retinoids Topical March 2022
Ulcerative Colitis Agents Oral March 2022
Ulcerative Colitis Agents Rectal March 2022
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
Anticholinergics LABAs ICS Combos and PDE4 Inhibitors March 2022
Anticholinergics Long Acting Beta Adrenergics Combos March 2022
Anticholinergics Long Acting Inhaled March 2022
Anticholinergics Short Acting and Combos Inhaled March 2022
Antihistamines Ophthalmic March 2022
Antiparasitics Topical March 2022
Atopic Dermatitis Agents Immunomodulators March 2022
Beta Adrenergic Agents Short Acting March 2022
Beta Adrenergic Agents Long Acting March 2022
Beta Adrenergic Agents Nebulized March 2022
Corticosteroids Ophthalmic Soft March 2022
Hepatitis C Agents March 2022
Leukotriene Receptor Modifiers March 2022
Pancreatic Enzymes March 2022
Respiratory Monoclonal Antibodies March 2022
Page
Drug Prior Authorization Committee Meeting Information